-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CKD-516 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CKD-516 in Solid Tumor Drug Details: CKD-516 (NOV-120401) is under development for the treatment...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – tuvatexib
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry tuvatexib Drug Details Tuvatexib (VDA-1102) is under development for the treatment of actinic keratosis,...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – CKD-516
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CKD-516 Drug Details CKD-516 (NOV-120401) is under development for the treatment of advanced solid...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – denibulin hydrochloride
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry denibulin hydrochloride Drug Details Denibulin hydrochloride (MN-029) is under development for the treatment of...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – BNC-105
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry BNC-105 Drug Details BNC-105 is under development for the treatment of metastatic colorectal cancer,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.